Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2830
www.abbvie.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc.
Piper Sandler Raises AbbVie (ABBV) Price Target to $289, Maintains Overweight Rating
- Nov 7th, 2025 10:36 pm
November 2025's Top Stocks Priced Below Estimated Value
- Nov 7th, 2025 10:38 am
The Top 5 Analyst Questions From AbbVie’s Q3 Earnings Call
- Nov 6th, 2025 10:32 pm
Record Earnings for Gubra; Revised Outlook for the CRO Business
- Nov 6th, 2025 9:30 am
Chronic Heart Failure Market Analysis and Forecast, 2025-2035, Featuring AstraZeneca, Bristol Myers Squibb, Cytokinetics, Bayer, Eli Lilly and Other Leading Players
- Nov 6th, 2025 8:23 am
3 Dividend Stocks Down 11%, 29%, and 41% to Buy in November
- Nov 6th, 2025 6:45 am
Former blockbuster Linzess grows label with paediatric IBS-C approval
- Nov 6th, 2025 5:35 am
REGENXBIO Reports Third Quarter 2025 Financial Results and Operational Highlights
- Nov 6th, 2025 5:05 am
Lower interest rates could boost these stocks & sectors
- Nov 6th, 2025 4:30 am
Jim Cramer Says “I Found the AbbVie Call Particularly Jarring”
- Nov 5th, 2025 9:11 pm
AbbVie Just Raised Its Dividend by 5.5%. Should You Buy ABBV Stock Here?
- Nov 5th, 2025 5:30 pm
Choroidal Neovascularization Market to Witness Accelerated Growth Throughout the Forecast Period (2025–2034) Due to Advancement in Anti-VEGF Therapies | DelveInsight
- Nov 5th, 2025 11:00 am
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
- Nov 5th, 2025 7:00 am
GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report
- Nov 5th, 2025 6:00 am
Calico Life Sciences Announces U.S. FDA Orphan Drug Designation for Investigational Treatment of Autosomal Dominant Polycystic Kidney Disease
- Nov 5th, 2025 6:00 am
3 Stocks Estimated To Be Trading Below Fair Value In November 2025
- Nov 4th, 2025 10:38 am
Hyperlipidemia Drugs Market Report 2025: $24.74 Industry Led by Pfizer, Merck & AbbVie, With Asia-Pacific Poised for Strong Growth Amid Trade-Driven Supply Chain Shifts - Global Forecast to 2034
- Nov 4th, 2025 7:45 am
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Apple, AbbVie, Broadcom, CyberArk, Palantir Technologies and More
- Nov 4th, 2025 7:11 am
3 Stocks Estimated To Be Trading Up To 25.8% Below Intrinsic Value
- Nov 4th, 2025 4:38 am
2 Healthcare Stocks for Individual Investors With a 10-Year Time Horizon
- Nov 4th, 2025 3:15 am
Scroll